ESTRO Vision 2030.
"Radiation Oncology. Optimal Health for all, together."
If, by 2035, every cancer patient who needs radiotherapy has access to it, almost one million more lives will be saved every year worldwide.
The ESTRO membership 2021 is now open.
Toxicity of L19-Interleukin 2 combined with Stereotactic Body Radiotherapy: A phase I study - Read It
MRI-guided Radiation Therapy: An Emerging Paradigm in Adaptive Radiation Oncology - Read It
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial - Read It Corner
Multicenter, Randomised, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by UGT1A1 Status in Patients With Locally Advanced Rectal Cancer - Read It
2021 Physics Workshop webinar - 26 February